Amoxapine
Autor: | Gary W. Dawson, S. G. Jue, R. N. Brogden |
---|---|
Rok vydání: | 1982 |
Předmět: |
chemistry.chemical_classification
Depressive Disorder business.industry medicine.medical_treatment Loxapine Amoxapine Antidepressive Agents Tricyclic Pharmacology Placebo Imipramine Kinetics Electroconvulsive therapy chemistry Anesthesia Dibenzoxazepines Humans Medicine Antidepressant Drug Interactions Pharmacology (medical) Amitriptyline business Tricyclic medicine.drug |
Zdroj: | Drugs. 24:1-23 |
ISSN: | 0012-6667 |
DOI: | 10.2165/00003495-198224010-00001 |
Popis: | Synopsis: Amoxapine is an N-demethylated dibenzoxazepine closely related to the neuroleptic loxapine. Its tricyclic structure appears to give it antidepressant properties resembling imipramine and amitriptyline. In uncontrolled trials it was shown to have antidepressant activity in usual doses up to 200 to 400mg daily. In placebo and double-blind controlled studies comparing amoxapine with the standard tricyclic antidepressants imipramine and amitriptyline, it was shown to be comparable in efficacy with a possibly somewhat faster onset of improvement of selected symptoms of depression in some studies. Because of the small study groups and lack of placebo control, many reports do not show statistically significant differences of treatment over standard drugs. To date there have been no studies comparing amoxapine with electroconvulsive therapy. Side effects were qualitatively similar to standard drugs with a suggestion that in standard doses or overdose myocardial effects are mild. However, the final place of amoxapine in the therapy of depressed states is still to be decided. |
Databáze: | OpenAIRE |
Externí odkaz: |